TalkMed Group (SGX:5G3) EBIT per Share : S$0.04 (TTM As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is TalkMed Group EBIT per Share?

TalkMed Group's EBIT per Share for the six months ended in Dec. 2024 was S$0.03. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was S$0.04.

During the past 12 months, the average EBIT per Share Growth Rate of TalkMed Group was -6.90% per year. During the past 3 years, the average EBIT per Share Growth Rate was 8.70% per year. During the past 5 years, the average EBIT per Share Growth Rate was 0.90% per year. During the past 10 years, the average EBIT per Share Growth Rate was -3.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for TalkMed Group's EBIT per Share or its related term are showing as below:

SGX:5G3' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -97.8 Med: -7.05 Max: 9.6
Current: 8.7

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of TalkMed Group was 9.60% per year. The lowest was -97.80% per year. And the median was -7.05% per year.

SGX:5G3's 3-Year EBIT Growth Rate is ranked better than
50.89% of 507 companies
in the Healthcare Providers & Services industry
Industry Median: 8 vs SGX:5G3: 8.70

TalkMed Group's EBIT for the six months ended in Dec. 2024 was S$38.51 Mil.

TalkMed Group EBIT per Share Historical Data

The historical data trend for TalkMed Group's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TalkMed Group EBIT per Share Chart

TalkMed Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

0.02

0.03

0.04

TalkMed Group Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EBIT per Share	Get a 7-Day Free Trial															0.02	0.01	0.02	0.01	0.03

TalkMed Group EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

TalkMed Group's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	49.712	/	1338.574
=	0.04

TalkMed Group's EBIT per Share for the quarter that ended in Dec. 2024 is calculated as

	EBIT per Share		(Q: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	38.513	/	1338.574
=	0.03

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was S$0.04

TalkMed Group (SGX:5G3) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

TalkMed Group EBIT per Share Related Terms

Thank you for viewing the detailed overview of TalkMed Group's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

TalkMed Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TalkMed Group Ltd (SGX:5G3) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 Mount Elizabeth, Mount Elizabeth Hospital Level 2, Singapore, SGP, 228510

Website

https://www.talkmed.com.sg

TalkMed Group Ltd operates as an investment holding company. It is a provider of medical oncology, stem cell transplants and palliative care services, serving patients in Singapore and the region. Outside Singapore, the Group operates in Vietnam, Hong Kong and the People's Republic of China. The activities of the company are the provision of medical oncology services and palliative care healthcare services in Singapore. It is organized into two reportable operating segments, Oncology Services and Cellular and gene therapy-related products and services. The company has operational footprints across Singapore, China and Hong Kong, Australia, Vietnam and others of which Singapore contributes the vast majority of total revenue. It generates maximum revenue from the Oncology services segment.

TalkMed Group Headlines

No Headlines